Highsmith W E, Burch L H, Zhou Z, Olsen J C, Strong T V, Smith T, Friedman K J, Silverman L M, Boucher R C, Collins F S, Knowles M R
Department of Pathology, University of Maryland, Baltimore 21201, USA.
Hum Mutat. 1997;9(4):332-8. doi: 10.1002/(SICI)1098-1004(1997)9:4<332::AID-HUMU5>3.0.CO;2-7.
A splicing mutation was identified at the +5 position of the splice donor site of exon 14b of CFTR in CF patients in a consanguineous family that is remarkable for unusually mild disease. Quantitative studies of nasal epithelial mRNA revealed that homozygotes for the spice site mutation produced approximately 4% of the normal amount of normally-spliced CFTR. We propose that this small amount of normally spliced mRNA is associated with synthesis of some normal CFTR protein, and accounts for the mild phenotype. Further characterization of epithelial function and clinical phenotype in patients bearing this form of mutation, termed a type V mutation, will be useful in determining the level of CFTR associated with amelioration of lung disease.
在一个近亲家庭的囊性纤维化(CF)患者中,CFTR基因外显子14b剪接受体位点的+5位置发现了一个剪接突变,该家庭的疾病异常轻微,这一点很显著。对鼻上皮mRNA的定量研究表明,剪接位点突变的纯合子产生的正常剪接CFTR的量约为正常量的4%。我们认为,这少量的正常剪接mRNA与一些正常CFTR蛋白的合成有关,并解释了该轻微表型。对携带这种形式突变(称为V型突变)的患者的上皮功能和临床表型进行进一步表征,将有助于确定与改善肺部疾病相关的CFTR水平。